影响2型糖尿病BMI和高血压之间的关系的肝脏指标:调解分析
Xuelin Yao1, Keyan Hu1, Zhen Wang1
1Department of Endocrinology, First Affiliated Hospital of Anhui Medical University, 218 Jixi Road, Shushan District, 230032, Hefei, China.
体重指数 (BMI) 影响糖尿病患者的高血压,肝脏酶如ALT,AST和GGT起着调解作用. 了解这些肝脏指标为糖尿病管理中的高血压干预提供了新的途径.
科学领域:
- 代谢综合征是代谢综合征的一种.
- 心血管疾病研究研究
- 糖尿病并发症 糖尿病并发症
背景情况:
- 体重指数 (BMI) 是糖尿病患者高血压的已知危险因素,但其潜在机制尚未完全理解.
- 来自肝脏的生物中间体在糖尿病病理生理学中至关重要,但它们在糖尿病中的BMI-高血压联系中的作用仍未得到充分探索.
研究的目的:
- 研究特定肝酶在2型糖尿病 (T2DM) 患者的BMI和高血压之间关系中的调解作用.
主要方法:
- 利用了来自中国全国糖尿病慢性并发症研究队列的1765名参与者的数据.
- 采用多变量回归和调解分析,根据年龄,糖尿病持续时间,葡萄糖水平和病史等因素进行调整.
- 在BMI与高血压的关联中评估了肝脏指标 (ALT,AST,GGT,AST/ALT比率) 的功能.
主要成果:
- 在男性中,BMI与高血压的关联显著介于ALT (68.67%),AST (27.02%),GGT (38.58%) 和AST/ALT比率 (63.35%).
- 在女性中,观察到ALT (36.93%),AST (37.47%),GGT (44.60%) 和AST/ALT比率 (43.73%) 的中介比例.
- 所有的调解效应都具有统计学意义 (P < 0.05).
结论:
- 肝脏指标,包括ALT,AST,GT和AST/ALT比率,部分介导着BMI对糖尿病患者高血压的影响.
- 这些发现表明,在糖尿病患者中管理高血压的潜在新治疗点.
更多相关视频
08:04Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Obesity
Hypertension and Regulation of Blood Pressure
